ARCT compared with BLSH: revenue, margins and what each company keeps, and the suppliers and customers both name

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

BLSHBullish

Mkt capRevenueRevenue

Compare

ARCTArcturus Therapeutics Holdings Inc.

BLSHBullish

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ARCT 3

—Biomedical Advanced Research and Development Authority (BARDA)unlistedcustomer

—CSL Seqirusunlistedcustomer

—Meiji Seika Pharmaunlistedcustomer

Shared 0

No shared counterparties.

Only BLSH 4

—Deloitte & Touche LLPunlistedsupplier

—BitGounlistedsupplier

—Fireblocksunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

SPV KY

unlistedsupplier

ARCTArcturus Therapeutics Holdings Inc.

9.47▼−14.15%· post 9.47· delayed

Mkt cap$313.5MRevenue$3MQ2 FY26Revenue$82MFY25

BLSHBullish

22.51▼−5.83%· post 22.56· delayed

After hoursNov 2 '26delayed

Mkt cap$3.6BRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

ARCTArcturus Therapeutics Holdings Inc.

BLSHBullish

9.47▼−14.15%post 9.47delayed

Price

22.51▼−5.83%post 22.56delayed

$313.5M

Mkt cap

$3.6B

Q2 FY26$3M

Revenue

—

FY25$82M

Revenue

—

ARCT9.47▼−14.15%vsBLSH22.51▼−5.83%After hoursNov 2 '26delayed